TRY 700 Million Investment from World Medicine

The foundation of an additional 23,300-square-meter manufacturing facility was laid in Çerkezköy

TRY 700 million investment from World Medicine

Operating in Türkiye since 2011, World Medicine continues its investments without slowing down. By laying the foundation for the construction of a new additional manufacturing facility and packaging area on a 17,582-square-meter site in Çerkezköy, World Medicine continues to work toward its goal of becoming the pharmaceutical company that contributes the most to the Turkish economy.

With its new additional manufacturing facility and packaging area investment in Çerkezköy, World Medicine has taken another important step toward its goal of exporting medicines produced in Türkiye to the world. Through its investments, the company continues to grow both in Türkiye and in the international pharmaceutical industry.

TRY 700 million investment

Stating that they had commissioned one of Türkiye’s largest pharmaceutical manufacturing facilities in the Çerkezköy Organized Industrial Zone last year, Sohrab Mammadli, Vice Chairman of the Board of Directors of World Medicine, said: “Our manufacturing facility, which has one of Türkiye’s largest production areas and high-technology machinery, also includes laboratories equipped with advanced devices that enable us to carry out many analyses with ease. Once our additional manufacturing facility investment, for which we recently laid the foundation with an investment of approximately TRY 700 million and which will be built on an area of 17,582 square meters, is completed, it will have a total enclosed area of 23,300 square meters.”

We are increasing our pharmaceutical production every day

Noting that they will continue their investments in 2023 in order to create added value both for the sector and for the Turkish economy, Sohrab Mammadli said: “In addition to the products we offer to the Turkish market, we continue our initiatives to increase the number of countries to which we export. Being a reliable business partner and a leading company in all countries and fields where we operate is very important for us. We are strengthening our infrastructure for greater pharmaceutical exports and increasing our manufacturing capacity every day with our production facilities equipped with advanced technology.”